Funding for this research was provided by:
national institute of allergy and infectious diseases (1U19AI144297)
Received: 30 June 2021
Accepted: 18 August 2021
First Online: 1 October 2021
: The Baylor College of Medicine Institutional Review Board (IRB) approved this study under the protocol H-47423. The IRB approved verbal consent due to the only contact with patients being by phone, and some participants were no longer residing in the USA.
: Consent to publish relevant information was obtained from all individuals in this study.
: The authors declare that they have no competing interests.